Responses
ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006
0185: Biweekly Paclitaxel/Carboplatin (Tc) Combination Chemotherapy is Highly Active and Well-Tolerated Treatment in First Line Chemotherapy for Ovarian Cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.